Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. by Kan, S, Elanko, N, Johnson, D, Cornejo-Roldan, L, Cook, J, Reich, E, Tomkins, S, Verloes, A, Twigg, SR, Rannan-Eliya, S, McDonald-McGinn, D, Zackai, E, Wall, SA, Muenke, M, Wilkie, A